查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2086951

機器人內視鏡設備：市場洞察、競爭格局與市場預測（2034 年）

Robotic Endoscopy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

機器人內視鏡設備市場概述

概述：

  • 預計到 2025 年，機器人內視鏡設備市場價值將達到 28.5 億美元，到 2034 年將達到 65.5 億美元。這一成長是由人們對微創手術的偏好日益增加、機器人支氣管鏡和人工智慧輔助導航的普及以及癌症和胃腸道疾病負擔的加重所推動的。
  • 全球機器人內視鏡設備市場預計在 2026 年至 2034 年的預測期內將以 9.7% 的複合年成長率成長。
  • 按產品類型分類，預計到 2025 年，治療類產品將佔市場佔有率的 57%，從而推動機器人內視鏡設備市場的發展。
  • 按應用領域分類，預計到 2025 年，腹腔鏡手術將佔 38% 的市場佔有率，引領機器人內視鏡設備市場。
  • 按技術分類，人工智慧輔助導航領域預計將引領機器人內視鏡設備市場，到 2025 年將佔 46% 的市場佔有率。
  • 以最終用戶分類，預計到 2025 年，醫院領域將引領機器人內視鏡設備市場，佔據 64% 的市場佔有率。
  • 預計到 2025 年，北美將佔據 42% 的市場佔有率，推動全球機器人內視鏡設備市場的銷售，並在全球範圍內取得最高的市場佔有率。

機器人內視鏡設備是一種先進的醫療系統，它結合了機器人平台、高解析度成像和人工智慧輔助導航技術，可在胃腸病學、呼吸系統疾病和外科領域進行微創診斷和治療手術。透過將精準的機器人控制與軟性內視鏡結合，這些系統使醫生能夠以優於傳統內視鏡的操控性、穩定性和精確度，在複雜的解剖結構中游刃有餘，同時還能減輕操作者的疲勞並提高手術的可重複性。此類別涵蓋診斷和治療設備，包括機器人內視鏡、影像和視覺化系統以及手術機器人，應用於大腸鏡檢查、支氣管鏡檢查、腹腔鏡檢查和胃腸內視鏡檢查。核心技術包括人工智慧輔助導航和影像分析、電磁感應和錐狀射束CT引導、軟性微型機器人內視鏡、遠端機器人操作以及雲端連接平台。這些設備的應用範圍正在醫院、門診手術中心和專科診所不斷擴大。近年來，機器人支氣管鏡技術憑藉其對周圍肺結節的診斷能力，以及人工智慧輔助的息肉和病變檢測技術，已成為一個快速發展的領域，診斷準確率也顯著提高。此外，各大醫療設備製造商正將機器人技術、診斷影像和分析功能整合到外科手術生態系統中，機器人內視鏡技術也日益成為現代篩檢和治療的標準工具。

機器人內視鏡設備市場的主要市場促進因素

  • 人們對微創手術的偏好日益成長，推動了其應用。機器人內視鏡具有更高的精準度、可操作性和穩定性，同時還能縮短恢復時間並降低併發症率。
  • 隨著全球癌症和消化系統疾病負擔的加重，相關手術的數量也增加。國際癌症研究機構（IARC）預測，癌症患者人數將從 2022 年的 2,000 萬人增加到 2050 年的 3,500 萬人。
  • 機器人支氣管鏡的迅速普及改善了對周圍肺結節的檢查，而人工智慧平台則使診斷準確率遠遠超過了傳統支氣管鏡。
  • 人工智慧驅動的導航和影像分析增強​​了病灶檢測、手術指導和即時決策支持，從而提高了診斷準確性和臨床信心。
  • 主要製造商正在加快獲得監管部門批准和推出其平台，導致支氣管鏡檢查、胃腸內視鏡檢查和軟組織手術領域採用的設備數量增加。
  • 隨著人口老化和大腸直腸癌和肺癌篩檢數量的增加，對機器人輔助診斷和治療內視鏡的需求日益成長。
  • 受微創治療需求、疾病負擔、人工智慧導航和平台創新等因素的推動，預計到 2034 年，該市場將保持強勁成長。

推動機器人內視鏡設備市場成長的因素

市場促進因素

人們越來越傾向選擇微創手術

推動機器人內視鏡設備市場發展的最強動力是醫生、患者和保險公司對微創診斷和治療程序的日益青睞。機器人內視鏡系統具有高精準度、更佳的操作性、更清晰的3D視覺化效果、防手震和符合人體工學的主機，可減輕外科醫生的疲勞，使其能夠處理時間更長、更複雜的手術。與傳統內視鏡和開放性手術相比，這些系統可縮短恢復時間、降低併發症發生率和再入院率，從而改善臨床療效並提高醫療成本效益。門診診所和手術中心受益於處理能力和效率的提升，而醫院則正在採用這些平台來提高手術精度並最佳化收入週期。手術量成長強勁，主要機器人平台均達到了兩位數的成長率。隨著微創醫學逐漸成為治療胃腸道、呼吸系統、泌尿系統和軟組織疾病的標準選擇，對機器人內視鏡的需求不斷成長，預計將持續推動市場成長至2034年。

全球癌症和胃腸道疾病負擔日益加重

全球癌症和胃腸道疾病負擔日益加重，推動了內視鏡手術數量和複雜性的增加。根據國際癌症研究機構（IARC）的數據，2022年新患者達2,000萬例，預計2050年將達到3,500萬例。此外，大腸直腸癌和肺癌這兩種最常見的惡性腫瘤，高度依賴內視鏡篩檢、診斷和治療。胃腸道疾病也十分普遍，根據2023年的一項分析估計，光在歐洲就有約3.32億人受到影響。機器人輔助內視鏡透過改善解剖結構複雜區域的操作，提高病變檢出的準確性，並實現諸如內視鏡黏膜下剝離術（ESD）等精準治療性介入，直接滿足了這一需求。癌症發病率的上升、人口老化以及篩檢計畫的擴展，正在推動用於診斷和治療的內視鏡手術數量的增加，預計這將直接增加預測期內對機器人平台的需求。

市場限制因素

儘管機器人內視鏡設備市場發展勢頭強勁，但仍面臨諸多限制因素。機器人系統的高昂初始投資成本，加上耗材、配件、服務合約和設備升級等方面的巨額支出，構成了一項重大障礙，尤其對於資源匱乏地區的小規模醫院、門診中心和醫療機構而言，保險報銷可能無法完全抵消投資成本。此外，機器人平台的複雜性要求外科醫生和工作人員接受專門培訓和熟練操作，而訓練有素的操作人員短缺會導致部署和使用延誤。監管和臨床檢驗要求延長了研發週期，並要求嚴格的安全性和有效性證據。持續的軟體和人工智慧更新也需要持續的上市後監測。不同地區和適應症的機器人手術保險報銷情況不盡相同，這影響了投資回報率並限制了其應用。對供應鏈和貿易措施的依賴，包括主要醫療設備製造商報告的關稅等成本增加因素，都增加了財務和營運風險。機器人平台、醫學影像系統和醫院IT系統之間的互通性，以及連網和雲端系統中資料隱私和網路安全的擔憂，進一步加劇了這一局面。激烈的競爭和核心專利的到期推動了創新，同時也擠壓了利潤空間。成本、培訓、監管、保險報銷、供應鏈和整合等方面的障礙，儘管存在著對微創治療、疾病負擔和人工智慧導航等強勁的潛在促進因素，但這些因素加在一起，正在減緩成長速度。

可以從以下幾個方面評估競爭格局：

  • 市場集中度：市場集中度日益提高，直覺式手術技術佔據主導地位。此外，由於資本密集、缺乏臨床證據以及現有使用者群體的鎖定效應，進入門檻很高。
  • 主要公司包括直覺外科、美敦力、強生醫療科技、奧林巴斯、波士頓科學和富士膠片，它們構成了頂級公司。
  • 地理擴張：領先企業擁有全球銷售和服務網路，並正在推行快速擴張計劃，目標是亞太地區和新興市場。
  • 產品系列優勢：領先企業提供涵蓋手術機器人、機器人支氣管鏡、內視鏡系統、手術器械和人工智慧軟體的綜合產品組合。
  • 開發平臺優勢：我們在軟組織機器人、機器人支氣管鏡、人工智慧導航和軟性微型管腔機器人方面擁有活躍的開發平臺。
  • 策略聯盟：我們透過與強生公司、英偉達公司、GE醫療集團、Medtronic和Cosmo智慧醫療設備公司等運算和成像供應商的合作，不斷擴大自身能力。
  • 併購活動：產業重組仍在繼續，包括 KARL STORZ 收購 Asensus Surgical 和強生公司收購 Auris Health（MONARCH 的基礎）。
  • 製造能力：機器人系統、一次性內視鏡和手術器械的大規模生產是一項重要的競爭優勢，也是供應鏈中的關鍵考慮因素。
  • 我們的創新重點是人工智慧輔助導航、用於治療周圍肺結節的機器人支氣管鏡檢查、能源和儀器，以及雲端連接的外科手術生態系統。

常問問題：

問題1：機器人內視鏡設備市場的成長率是多少？

預計從 2026 年到 2034 年的預測期內，機器人內視鏡設備市場將以 9.7% 的複合年成長率成長。

Q2. 機器人內視鏡設備市場的市場規模有多大？

預計到 2025 年，機器人內視鏡設備市場價值將達到 28.5 億美元，預計到 2034 年將達到 65.5 億美元。

Q3. 哪個地區正在推動機器人內視鏡設備市場的發展？

預計到2025年，北美將引領機器人內視鏡設備市場，佔全球銷售額的42%，這主要得益於其世界領先的機器人手術普及率、製造商高度集中、完善的保險報銷體系、強勁的FDA核准勢頭，以及所有三種FDA已通過核准的機器人支氣管鏡平台的主導。亞太地區預計將成為預測期內成長最快的地區。

第四季：機器人內視鏡設備市場的主要促進因素是什麼？

關鍵促進因素包括：人們越來越傾向於微創手術；全球癌症和胃腸道疾病負擔日益加重（國際癌症研究機構 (IARC) 預測，癌症患者人數將從 2022 年的 2000 萬增加到 2050 年的 3500 萬）；機器人支氣管鏡在周圍肺結節診斷中的快速應用病變；

Q5. 機器人內視鏡設備市場的主要參與者有哪些？

主要廠商包括Intuitive Surgical, Inc.、強生醫療科技公司（Johnson & Johnson MedTech）、美敦力公司（Medtronic plc）、奧林巴斯株式會社（Olympus Corporation）、波士頓科學公司（Boston Scientific Corporation）、富士底片公司控股株式會社（FUJIFM Holdings Corporation. SEJ.M Holdings Corporation）、史賽克？ KG）、Asensus Surgical, Inc.和CMR Surgical Ltd.。此外，其他在「競爭格局」部分介紹的主要廠商，以及Noah Medical和Virtuoso Surgical等新興企業也正在進入市場。 Intuitive Surgical, Inc.在機器人軟組織技術和機器人支氣管鏡領域佔據主導地位。

目錄

第1章：機器人內視鏡設備市場報告簡介

  • 調查範圍
  • 市場區隔
  • 市場假設

第2章：機器人內視鏡設備市場執行摘要

  • 市場概覽

第3章：機器人內視鏡設備市場關鍵因素分析

  • 機器人內視鏡設備市場：市場促進因素
    • 人們越來越傾向微創手術
    • 癌症和胃腸道疾病負擔日益加重
    • 機器人支氣管鏡和人工智慧導航技術的普及
    • 加速法規核准和平台上推出
  • 機器人內視鏡設備市場的市場限制與挑戰
    • 高昂的資本投資成本和償還金額的波動性
    • 培訓、學習曲線和人力資源限制
    • 與監管、供應鏈和一體化相關的障礙
  • 機器人內視鏡設備市場：市場機遇
    • 機器人支氣管鏡檢查及管腔內機器人技術
    • 門診手術中心及向新興市場的擴張

第4章 影響分析：人工智慧、地緣政治、貿易和經濟趨勢

第5章：監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第6章：機器人內視鏡設備市場：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭公司之間的競爭

第7章：機器人內視鏡設備市場評估

  • 依產品類型
    • 用於治療的機器人輔助內視鏡
    • 診斷機器人內視鏡
  • 透過使用
    • 腹腔鏡
    • 支氣管鏡檢查
    • 大腸鏡檢查
    • 胃腸內視鏡檢查
    • 其他
  • 透過技術
    • 人工智慧輔助導航
    • 電磁導航
    • 形狀檢測導航
    • 錐狀射束CT與透視引導
    • 標準影像顯示系統
  • 最終用戶
    • 醫院
    • 門診手術中心
    • 專科診所
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 世界其他地區

第8章：機器人內視鏡設備市場的競爭格局

  • 市場集中度與結構
  • 競爭定位與市場佔有率分析（加值服務）

第9章：機器人內視鏡設備市場的新創企業資金籌措與投資趨勢

第10章：機器人內視鏡設備市場：公司概況與產品概況

  • Intuitive Surgical, Inc.
    • 公司簡介
    • 公司簡介
    • 財務概覽
    • 產品系列
    • 策略舉措/熵
  • Johnson & Johnson MedTech
  • Medtronic plc
  • Olympus Corporation
  • Boston Scientific Corporation
  • FUJIFILM Holdings Corporation
  • Stryker Corporation
  • KARL STORZ SE & Co. KG
  • Asensus Surgical, Inc.
  • CMR Surgical Ltd.

第11章：KOL的觀點

第12章：專案式教學方法

第13章：關於 DelveInsight

第14章 免責聲明與聯絡方式

Product Code: DIMDCL0938

Robotic Endoscopy Devices Market Summary

Overview:

  • The Robotic Endoscopy Devices market is estimated at USD 2.85 billion in 2025 and is projected to reach USD 6.55 billion by 2034. Growth is anchored in the rising preference for minimally invasive procedures, the expansion of robotic bronchoscopy and AI-assisted navigation, and the growing burden of cancer and gastrointestinal disease.
  • The global Robotic Endoscopy Devices market is growing at a CAGR of 9.7% during the forecast period from 2026 to 2034.
  • By product type, the therapeutic segment dominated the Robotic Endoscopy Devices market with a 57% share in 2025.
  • By application, the laparoscopy segment dominated the Robotic Endoscopy Devices market with a 38% share in 2025.
  • By technology, the AI-assisted navigation segment dominated the Robotic Endoscopy Devices market with a 46% share in 2025.
  • By end user, the hospitals segment dominated the Robotic Endoscopy Devices market with a 64% share in 2025.
  • North America dominated the global Robotic Endoscopy Devices market revenue with a 42% share in 2025, representing the highest regional market share globally.

Robotic endoscopy devices are advanced medical systems that combine robotic platforms, high-definition imaging, and AI-assisted navigation to perform minimally invasive diagnostic and therapeutic procedures across gastrointestinal, respiratory, and surgical applications. By pairing precision robotic control with flexible endoscopes, these systems enable physicians to navigate complex anatomy with greater dexterity, stability, and accuracy than conventional endoscopy, while reducing operator fatigue and improving reproducibility. The category spans diagnostic and therapeutic devices, including robotic endoscopes, imaging and visualization systems, and surgical robots, deployed for colonoscopy, bronchoscopy, laparoscopy, and gastrointestinal endoscopy. Core technologies include AI-assisted navigation and image analysis, electromagnetic and cone-beam CT guidance, flexible and miniaturized robotic endoscopes, and tele-robotic and cloud-connected platforms. Adoption extends across hospitals, ambulatory surgical centers, and specialized clinics. Over the past several years, robotic bronchoscopy has emerged as a fast-growing segment for reaching peripheral lung nodules, AI-powered polyp and lesion detection has improved diagnostic yield, and major device companies have integrated robotics, imaging, and analytics into connected surgical ecosystems, positioning robotic endoscopy as an increasingly standard tool in modern screening and intervention.

Robotic Endoscopy Devices Market Key Growth Drivers

  • The rising preference for minimally invasive procedures is driving adoption, as robotic endoscopy delivers greater precision, dexterity, and stability with shorter recovery times and lower complication rates.
  • The growing global burden of cancer and gastrointestinal disease is expanding procedure volumes, with the International Agency for Research on Cancer projecting cancer cases to rise from 20 million in 2022 to 35 million by 2050.
  • The rapid expansion of robotic bronchoscopy is improving access to peripheral lung nodules, with AI-assisted platforms lifting diagnostic yield well above conventional bronchoscopy.
  • AI-assisted navigation and image analysis are enhancing lesion detection, procedural guidance, and real-time decision support, increasing diagnostic accuracy and clinical confidence.
  • Accelerating regulatory clearances and platform launches by leading manufacturers are expanding the installed base across bronchoscopy, GI endoscopy, and soft-tissue surgery.
  • Aging populations and rising colorectal and lung cancer screening volumes are increasing demand for robotic diagnostic and therapeutic endoscopy.
  • The convergence of minimally invasive demand, disease burden, AI navigation, and platform innovation is expected to sustain strong growth in the market through 2034.

Key Companies in Robotic Endoscopy Devices Market

The competitive landscape is led by the following active manufacturers and developers:

  • Intuitive Surgical, Inc.
  • Johnson & Johnson MedTech
  • Medtronic plc
  • Olympus Corporation
  • Boston Scientific Corporation
  • FUJIFILM Holdings Corporation
  • Stryker Corporation
  • KARL STORZ SE & Co. KG
  • Asensus Surgical, Inc.
  • CMR Surgical Ltd.

Factors Contributing to the Growth of the Robotic Endoscopy Devices Market

Market Drivers

Rising Preference for Minimally Invasive Procedures

The most powerful driver of the Robotic Endoscopy Devices market is the rising preference for minimally invasive diagnostic and therapeutic procedures among physicians, patients, and payers. Robotic endoscopy systems deliver high precision, improved dexterity, enhanced three-dimensional visualization, tremor filtration, and ergonomic consoles that reduce surgeon fatigue, enabling longer and more complex cases. Compared with conventional endoscopy and open surgery, these systems offer shorter recovery times, lower complication rates, and reduced readmissions, which improve clinical outcomes and the economics of care. Outpatient and ambulatory surgical centers benefit from higher throughput and efficiency, while hospitals adopt the platforms to improve accuracy and optimize revenue cycles. Procedure momentum is strong, with leading robotic platforms reporting double-digit procedure growth. As minimally invasive care becomes the standard expectation across gastrointestinal, respiratory, urological, and soft-tissue interventions, demand for robotic endoscopy expands, anchoring market growth through 2034.

Rising Global Burden of Cancer and Gastrointestinal Disease

The growing global burden of cancer and gastrointestinal disease is expanding the volume and complexity of endoscopic procedures. The International Agency for Research on Cancer recorded 20 million new cancer cases in 2022 and projects 35 million by 2050, while colorectal and lung cancers, among the most common malignancies, depend heavily on endoscopic screening, diagnosis, and intervention. Digestive disorders are also widespread, with a 2023 analysis estimating that over 332 million people are affected in Europe alone. Robotic endoscopy directly addresses this demand by improving access to difficult anatomy, enhancing lesion detection, and enabling precise therapeutic intervention such as endoscopic submucosal dissection. As cancer incidence rises, populations age, and screening programs expand, the number of diagnostic and therapeutic endoscopic procedures grows, directly increasing demand for robotic platforms across the forecast period.

Market Restraints

Despite strong momentum, the Robotic Endoscopy Devices market faces material constraints. The high capital cost of robotic systems, along with substantial expenditure on disposables, accessories, service contracts, and facility upgrades, is a significant barrier, particularly for smaller hospitals, ambulatory centers, and providers in lower-resource settings where reimbursement may not fully offset investment. The complexity of robotic platforms requires specialized training and a learning curve for surgeons and staff, and a shortage of trained operators can slow adoption and utilization. Regulatory and clinical-validation requirements lengthen development timelines and demand rigorous evidence of safety and benefit, while ongoing software and AI updates require continued post-market oversight. Reimbursement for robotic procedures remains uneven across geographies and indications, constraining the return on investment and limiting access. Supply-chain dependencies and trade measures, including tariffs that major device companies have reported will raise costs, add financial and operational risk. Interoperability between robotic platforms, imaging systems, and hospital IT, along with concerns about data privacy and cybersecurity in connected and cloud-based systems, adds further complexity. Intense competition and the expiration of core patents pressure margins, even as they spur innovation. Together, these cost, training, regulatory, reimbursement, supply-chain, and integration barriers temper the pace of growth, even as the underlying drivers of minimally invasive demand, disease burden, and AI navigation remain firmly intact.

Robotic Endoscopy Devices Market Segment Analysis

The Robotic Endoscopy Devices Market by Product Type (Therapeutic Robotic Endoscopes, Diagnostic Robotic Endoscopes), Application (Laparoscopy, Bronchoscopy, Colonoscopy, Gastrointestinal Endoscopy, Others), Technology (AI-Assisted Navigation, Electromagnetic Navigation, Shape-Sensing Navigation, Cone-Beam CT and Fluoroscopy Guidance, Standard Visualization Systems, Others), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others), and Geography (North America, Europe, Asia-Pacific, Rest of World).

By Product Type

Dominant Subsegment: Therapeutic Robotic Endoscopes. The therapeutic robotic endoscopes category is expected to dominate the market.

Dominant: Therapeutic Robotic Endoscopes ~ 57%

The therapeutic robotic endoscopes segment accounted for 57% of the Robotic Endoscopy Devices market in 2025. Therapeutic robotic endoscopes are the leading product type because they carry the highest clinical and economic value, enabling minimally invasive intervention as well as diagnosis across soft-tissue surgery, gastrointestinal therapy, and lung biopsy. These systems perform tissue resection, ablation, stenting, polypectomy, and robotic-assisted surgery, commanding premium pricing and generating recurring revenue from instruments, accessories, and disposables. The segment is anchored by high-profile platforms, including Intuitive Surgical's da Vinci 5 for soft-tissue surgery, Medtronic's Hugo robotic-assisted surgery system cleared for urologic procedures, and robotic bronchoscopy systems that biopsy and increasingly treat peripheral lung lesions. Continuous innovation in AI navigation, energy delivery, and instrumentation deepens therapeutic capability and adoption. Diagnostic robotic endoscopes, including capsule robots and imaging robots, are growing as screening expands, but therapeutic systems retain leadership on the strength of procedure value, recurring consumable revenue, and a deep pipeline of surgical and interventional platforms across the forecast period.

By Application

Dominant Subsegment: Laparoscopy. The laparoscopy category is expected to dominate the market.

Dominant: Laparoscopy ~ 38%

The laparoscopy segment accounted for 38% of the Robotic Endoscopy Devices market in 2025. Laparoscopy is the leading application because robotic-assisted soft-tissue surgery represents the largest and most established robotic procedure base, spanning urology, gynecology, and general surgery at high volumes in hospitals worldwide. Robotic platforms deliver superior dexterity, stability, three-dimensional visualization, and ergonomics compared with manual laparoscopy, driving sustained adoption and a growing installed base. The segment is reinforced by a wave of platform competition, including Intuitive Surgical's da Vinci 5, Medtronic's Hugo, Johnson & Johnson's Ottava, and CMR Surgical's Versius Plus, which is expanding access and procedure volumes. While robotic bronchoscopy is among the fastest-growing applications, propelled by demand to reach peripheral lung nodules, and colonoscopy and gastrointestinal endoscopy expand with screening, the scale, maturity, and procedure value of laparoscopic robotic surgery secure its leadership across the forecast period, supported by recurring instrument and accessory revenue.

By End User

Dominant Subsegment: Hospitals. The hospitals category is expected to dominate the market.

Dominant: Hospitals ~ 64%

The hospitals segment accounted for 64% of the Robotic Endoscopy Devices market in 2025. Hospitals are the largest end user because they perform the highest volume of complex robotic and endoscopic procedures and have the capital, infrastructure, and specialist staff to acquire and operate premium robotic platforms. Robotic-assisted surgery, robotic bronchoscopy, and advanced gastrointestinal intervention concentrate in hospitals and academic medical centers, which anchor the installed base for high-value systems from Intuitive Surgical, Medtronic, Johnson & Johnson, and Olympus. Hospital adoption is reinforced by the breadth of procedures, the availability of training and support, and the ability to absorb the high upfront cost of robotic systems and service contracts. At the same time, ambulatory surgical centers are a fast-growing channel, supported by reimbursement changes that move procedures into outpatient settings and by platforms designed for outpatient workflows, while specialty clinics expand access. Nonetheless, the volume, acuity, and infrastructure of hospitals secure their clear leadership across the forecast period.

Robotic Endoscopy Devices Market Region Analysis

Dominant Region: North America

North America accounted for 42% of the global Robotic Endoscopy Devices market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects the world's highest robotic surgery adoption, advanced healthcare infrastructure, strong reimbursement, and the concentration of leading manufacturers, particularly in the United States. North America hosts the headquarters and primary markets of Intuitive Surgical, Medtronic, Johnson & Johnson MedTech, Boston Scientific, and Stryker, and benefits from a steady cadence of FDA clearances, including Medtronic's Hugo, CMR Surgical's Versius Plus, and Johnson & Johnson's MONARCH QUEST. The United States leads in robotic bronchoscopy and soft-tissue robotic surgery, with all three FDA-cleared robotic bronchoscopy platforms commercialized in the region. A Medicare reimbursement change effective in 2026 is accelerating the movement of procedures into ambulatory surgical centers, expanding access. Deep clinical expertise, supportive regulation, and strong investment anchor the region's continued leadership across the forecast period.

Dominant: North America ~ 42% (Largest)

Fastest Growing Region: Asia-Pacific

Asia-Pacific is the fastest-growing region in the Robotic Endoscopy Devices market. The region's elevated CAGR is driven by a large and aging population, a rising burden of cancer and gastrointestinal disease, expanding healthcare access, and growing investment in robotic surgery across China, Japan, India, South Korea, and Australia. Governments and hospitals are investing in minimally invasive surgical capacity, and regional and global manufacturers, including Olympus and FUJIFILM, are scaling endoscopy and robotic platforms. Rising screening volumes for colorectal and lung cancer, growing surgical demand, and increasing affordability of robotic systems are accelerating adoption in both urban and expanding healthcare networks. Local innovation and new lower-cost platforms are broadening access, positioning Asia-Pacific as the principal source of incremental growth over the forecast period.

Regional Commentary

North America

North America accounted for 42% of the global Robotic Endoscopy Devices market revenue in 2025. The United States dominates on the strength of the world's highest robotic surgery adoption, a dense base of manufacturers, strong reimbursement, FDA clearance momentum, and the commercialization of all three FDA-cleared robotic bronchoscopy platforms, while Canada contributes through hospital adoption and provincial screening programs.

Europe

Europe is a large and advanced regional market, led by Germany, the United Kingdom, France, Italy, and Spain. Growth is supported by strong healthcare systems, established surgical infrastructure, and a robust manufacturer base including KARL STORZ, CMR Surgical, and Olympus Europe, while CE marking and national health-technology assessment shape adoption of new robotic platforms across the region.

Asia-Pacific

Asia-Pacific is the fastest-growing region, propelled by a large aging population, rising cancer and gastrointestinal disease burden, expanding healthcare access, and growing investment in robotic surgery across China, Japan, India, South Korea, and Australia. Regional endoscopy leaders such as Olympus and FUJIFILM scale platforms, while rising screening volumes and new lower-cost robotic systems broaden access.

Rest of World

The Rest of World region, spanning Latin America, the Middle East, and Africa, is an emerging growth frontier. A rising burden of cancer and gastrointestinal disease, expanding hospital infrastructure, and growing demand for minimally invasive surgery are increasing adoption, while partnerships, training programs, and telemedicine are gradually extending access to robotic endoscopy across these markets.

Robotic Endoscopy Devices Market Competitive Landscape

The Robotic Endoscopy Devices market is classified as Consolidated. A small group of large medical-device companies controls the majority of revenue, with Intuitive Surgical holding a dominant position in soft-tissue robotic surgery and robotic bronchoscopy, followed by Medtronic, Johnson & Johnson MedTech, Olympus, Boston Scientific, and FUJIFILM across surgery and endoscopy. A growing field of challengers, including CMR Surgical, Asensus Surgical, and emerging players such as Noah Medical and Virtuoso Surgical, is intensifying competition as new platforms reach the market.

The competitive landscape can be evaluated across the following dimensions:

  • Market concentration: Consolidated, with Intuitive Surgical dominant and high barriers to entry from capital intensity, clinical evidence, and installed-base lock-in.
  • Leading players: Intuitive Surgical, Medtronic, Johnson & Johnson MedTech, Olympus, Boston Scientific, and FUJIFILM anchor the top tier.
  • Geographic reach: Leaders operate global commercial and service networks, with rapid expansion programs targeting Asia-Pacific and emerging markets.
  • Product portfolio strength: Top players offer integrated portfolios spanning surgical robots, robotic bronchoscopy, endoscopy systems, instruments, and AI software.
  • Pipeline strength: Active pipelines in soft-tissue robotics, robotic bronchoscopy, AI navigation, and flexible and miniaturized endoluminal robots.
  • Strategic partnerships: Collaborations with computing and imaging providers, such as Johnson & Johnson with NVIDIA and GE HealthCare, and Medtronic with Cosmo Intelligent Medical Devices, extend capability.
  • M&A activity: Consolidation continues, including KARL STORZ's acquisition of Asensus Surgical and Johnson & Johnson's acquisition of Auris Health, the basis of MONARCH.
  • Manufacturing capabilities: Scale manufacturing of robotic systems, single-use endoscopes, and instruments is a key competitive moat and supply-chain consideration.
  • Innovation focus: AI-assisted navigation, robotic bronchoscopy for peripheral lung nodules, energy and instrumentation, and cloud-connected surgical ecosystems.

Robotic Endoscopy Devices Market Recent Developmental Activities

In December 2025, Medtronic plc, received FDA clearance of the Hugo robotic-assisted surgery system for urologic procedures, its first United States soft-tissue indication and the first large-medtech soft-tissue robot cleared since the da Vinci. Strategic significance: Establishes a major competitor to Intuitive Surgical and expands hospital choice in robotic surgery.

In December 2025, CMR Surgical Ltd., received FDA 510(k) clearance for its Versius Plus system to perform cholecystectomy and posted nine-figure financing to support United States commercialization. Strategic significance: Adds a modular, portable robotic platform to the United States market and broadens access beyond academic centers.

In September 2025, Virtuoso Surgical, Inc., received FDA breakthrough device designation for its dual-arm endoscopic surgical robot for endoluminal intervention. Strategic significance: Advances next-generation endoluminal robotics and signals continued innovation in flexible robotic endoscopy.

Robotic Endoscopy Devices Market Segmentation

Robotic Endoscopy Devices Market by Product Type

  • Therapeutic Robotic Endoscopes
  • Surgical Robots
  • Ablation and Resection Systems
  • Stenting and Therapeutic Devices
  • Diagnostic Robotic Endoscopes
  • Capsule Robots
  • Imaging Robots

Robotic Endoscopy Devices Market by Application

  • Laparoscopy
  • Bronchoscopy
  • Colonoscopy
  • Gastrointestinal Endoscopy
  • Others

Robotic Endoscopy Devices Market by Technology

  • AI-Assisted Navigation
  • Electromagnetic Navigation
  • Shape-Sensing Navigation
  • Cone-Beam CT and Fluoroscopy Guidance
  • Standard Visualization Systems
  • Others

Robotic Endoscopy Devices Market by End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Others

Robotic Endoscopy Devices Market by Geography

  • North America Robotic Endoscopy Devices Market
  • United States Robotic Endoscopy Devices Market Size in USD million (2023-2034)
  • Canada Robotic Endoscopy Devices Market Size in USD million (2023-2034)
  • Mexico Robotic Endoscopy Devices Market Size in USD million (2023-2034)
  • Europe Robotic Endoscopy Devices Market
  • Germany Robotic Endoscopy Devices Market Size in USD million (2023-2034)
  • United Kingdom Robotic Endoscopy Devices Market Size in USD million (2023-2034)
  • France Robotic Endoscopy Devices Market Size in USD million (2023-2034)
  • Italy Robotic Endoscopy Devices Market Size in USD million (2023-2034)
  • Spain Robotic Endoscopy Devices Market Size in USD million (2023-2034)
  • Rest of Europe Robotic Endoscopy Devices Market Size in USD million (2023-2034)
  • Asia-Pacific Robotic Endoscopy Devices Market
  • China Robotic Endoscopy Devices Market Size in USD million (2023-2034)
  • Japan Robotic Endoscopy Devices Market Size in USD million (2023-2034)
  • India Robotic Endoscopy Devices Market Size in USD million (2023-2034)
  • Australia Robotic Endoscopy Devices Market Size in USD million (2023-2034)
  • South Korea Robotic Endoscopy Devices Market Size in USD million (2023-2034)
  • Rest of Asia-Pacific Robotic Endoscopy Devices Market Size in USD million (2023-2034)
  • Rest of the World (RoW) Robotic Endoscopy Devices Market
  • Middle East Robotic Endoscopy Devices Market Size in USD million (2023-2034)
  • Africa Robotic Endoscopy Devices Market Size in USD million (2023-2034)
  • South America Robotic Endoscopy Devices Market Size in USD million (2023-2034)

Frequently Asked Questions:

Q1. What is the growth rate of the Robotic Endoscopy Devices market?

The Robotic Endoscopy Devices market is projected to expand at a CAGR of 9.7% during the forecast period from 2026-2034.

Q2. What is the market size of the Robotic Endoscopy Devices market?

The Robotic Endoscopy Devices market is estimated at USD 2.85 billion in 2025 and is projected to reach USD 6.55 billion by 2034.

Q3. Which region dominates the Robotic Endoscopy Devices market?

North America dominated the Robotic Endoscopy Devices market with a 42% share of global revenue in 2025, supported by the world's highest robotic surgery adoption, a dense base of manufacturers, strong reimbursement, FDA clearance momentum, and the commercialization of all three FDA-cleared robotic bronchoscopy platforms. Asia-Pacific is the fastest-growing region over the forecast period.

Q4. What are the key drivers of the Robotic Endoscopy Devices market?

The principal drivers are the rising preference for minimally invasive procedures; the growing global burden of cancer and gastrointestinal disease, with the International Agency for Research on Cancer projecting cancer cases to rise from 20 million in 2022 to 35 million by 2050; the rapid expansion of robotic bronchoscopy for peripheral lung nodules; AI-assisted navigation and lesion detection; and accelerating regulatory clearances and platform launches by leading manufacturers.

Q5. Who are the major players in the Robotic Endoscopy Devices market?

The major players include Intuitive Surgical, Inc., Johnson & Johnson MedTech, Medtronic plc, Olympus Corporation, Boston Scientific Corporation, FUJIFILM Holdings Corporation, Stryker Corporation, KARL STORZ SE & Co. KG, Asensus Surgical, Inc., and CMR Surgical Ltd., among other active manufacturers profiled in the Competitive Landscape section, along with emerging players such as Noah Medical and Virtuoso Surgical. Intuitive Surgical leads in soft-tissue robotics and robotic bronchoscopy.

Table of Contents

1. Robotic Endoscopy Devices Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumptions

2. Robotic Endoscopy Devices Market Executive Summary

  • 2.1 Market at a Glance

3. Robotic Endoscopy Devices Market Key Factors Analysis

  • 3.1 Robotic Endoscopy Devices Market Drivers
    • 3.1.1 Rising Preference for Minimally Invasive Procedures
    • 3.1.2 Growing Burden of Cancer and Gastrointestinal Disease
    • 3.1.3 Expansion of Robotic Bronchoscopy and AI Navigation
    • 3.1.4 Accelerating Regulatory Clearances and Platform Launches
  • 3.2 Robotic Endoscopy Devices Market Restraints and Challenges
    • 3.2.1 High Capital Cost and Reimbursement Variability
    • 3.2.2 Training, Learning Curve, and Workforce Constraints
    • 3.2.3 Regulatory, Supply-Chain, and Integration Barriers
  • 3.3 Robotic Endoscopy Devices Market Opportunities
    • 3.3.1 Robotic Bronchoscopy and Endoluminal Robotics
    • 3.3.2 Ambulatory Surgical Center and Emerging-Market Expansion

4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments

5. Regulatory Analysis

  • 5.1 United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Robotic Endoscopy Devices Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Buyers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Robotic Endoscopy Devices Market Assessment

  • 7.1 By Product Type
    • 7.1.1 Therapeutic Robotic Endoscopes
      • 7.1.1.1 Surgical Robots
      • 7.1.1.2 Ablation and Resection Systems
      • 7.1.1.3 Stenting and Therapeutic Devices
    • 7.1.2 Diagnostic Robotic Endoscopes
      • 7.1.2.1 Capsule Robots
      • 7.1.2.2 Imaging Robots
  • 7.2 By Application
    • 7.2.1 Laparoscopy
    • 7.2.2 Bronchoscopy
    • 7.2.3 Colonoscopy
    • 7.2.4 Gastrointestinal Endoscopy
    • 7.2.5 Others
  • 7.3 By Technology
    • 7.3.1 AI-Assisted Navigation
    • 7.3.2 Electromagnetic Navigation
    • 7.3.3 Shape-Sensing Navigation
    • 7.3.4 Cone-Beam CT and Fluoroscopy Guidance
    • 7.3.5 Standard Visualization Systems
    • 7.3.6 Others
  • 7.4 By End User
    • 7.4.1 Hospitals
    • 7.4.2 Ambulatory Surgical Centers
    • 7.4.3 Specialty Clinics
    • 7.4.4 Others
  • 7.5 By Geography
    • 7.5.1 North America
      • 7.5.1.1 United States Robotic Endoscopy Devices Market Size in USD million (2023-2034)
      • 7.5.1.2 Canada Robotic Endoscopy Devices Market Size in USD million (2023-2034)
      • 7.5.1.3 Mexico Robotic Endoscopy Devices Market Size in USD million (2023-2034)
    • 7.5.2 Europe
      • 7.5.2.1 Germany Robotic Endoscopy Devices Market Size in USD million (2023-2034)
      • 7.5.2.2 United Kingdom Robotic Endoscopy Devices Market Size in USD million (2023-2034)
      • 7.5.2.3 France Robotic Endoscopy Devices Market Size in USD million (2023-2034)
      • 7.5.2.4 Italy Robotic Endoscopy Devices Market Size in USD million (2023-2034)
      • 7.5.2.5 Spain Robotic Endoscopy Devices Market Size in USD million (2023-2034)
      • 7.5.2.6 Rest of Europe Robotic Endoscopy Devices Market Size in USD million (2023-2034)
    • 7.5.3 Asia-Pacific
      • 7.5.3.1 China Robotic Endoscopy Devices Market Size in USD million (2023-2034)
      • 7.5.3.2 Japan Robotic Endoscopy Devices Market Size in USD million (2023-2034)
      • 7.5.3.3 India Robotic Endoscopy Devices Market Size in USD million (2023-2034)
      • 7.5.3.4 Australia Robotic Endoscopy Devices Market Size in USD million (2023-2034)
      • 7.5.3.5 South Korea Robotic Endoscopy Devices Market Size in USD million (2023-2034)
      • 7.5.3.6 Rest of Asia-Pacific Robotic Endoscopy Devices Market Size in USD million (2023-2034)
    • 7.5.4 Rest of World
      • 7.5.4.1 Middle East Robotic Endoscopy Devices Market Size in USD million (2023-2034)
      • 7.5.4.2 Africa Robotic Endoscopy Devices Market Size in USD million (2023-2034)
      • 7.5.4.3 South America Robotic Endoscopy Devices Market Size in USD million (2023-2034)

8. Robotic Endoscopy Devices Market Competitive Landscape

  • 8.1 Market Concentration and Structure
  • 8.2 Competitive Positioning and Market Share Analysis (Premium Offering)

9. Robotic Endoscopy Devices Market Startup Funding and Investment Trends

10. Robotic Endoscopy Devices Market Company and Product Profiles

  • 10.1 Intuitive Surgical, Inc.
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Product Portfolio
    • 10.1.5 Strategic Initiatives / Entropy
  • 10.2 Johnson & Johnson MedTech
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Portfolio
    • 10.2.5 Strategic Initiatives / Entropy
  • 10.3 Medtronic plc
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Portfolio
    • 10.3.5 Strategic Initiatives / Entropy
  • 10.4 Olympus Corporation
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Portfolio
    • 10.4.5 Strategic Initiatives / Entropy
  • 10.5 Boston Scientific Corporation
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Portfolio
    • 10.5.5 Strategic Initiatives / Entropy
  • 10.6 FUJIFILM Holdings Corporation
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Portfolio
    • 10.6.5 Strategic Initiatives / Entropy
  • 10.7 Stryker Corporation
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Portfolio
    • 10.7.5 Strategic Initiatives / Entropy
  • 10.8 KARL STORZ SE & Co. KG
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Portfolio
    • 10.8.5 Strategic Initiatives / Entropy
  • 10.9 Asensus Surgical, Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Portfolio
    • 10.9.5 Strategic Initiatives / Entropy
  • 10.10 CMR Surgical Ltd.
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Portfolio
    • 10.10.5 Strategic Initiatives / Entropy

For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer and Contact Us

List of Tables

  • Table 1: Robotic Endoscopy Devices Market in Global (2023-2034)
  • Table 2: Robotic Endoscopy Devices Market in Global by Product Type (2023-2034)
  • Table 3: Robotic Endoscopy Devices Market in Global by Application (2023-2034)
  • Table 4: Robotic Endoscopy Devices Market in Global by Technology (2023-2034)
  • Table 5: Robotic Endoscopy Devices Market in Global by End User (2023-2034)
  • Table 6: Robotic Endoscopy Devices Market in Global by Geography (2023-2034)
  • Table 7: Robotic Endoscopy Devices Market in North America (2023-2034)
  • Table 8: Robotic Endoscopy Devices Market in the United States (2023-2034)
  • Table 9: Robotic Endoscopy Devices Market in Canada (2023-2034)
  • Table 10: Robotic Endoscopy Devices Market in Mexico (2023-2034)
  • Table 11: Robotic Endoscopy Devices Market in Europe (2023-2034)
  • Table 12: Robotic Endoscopy Devices Market in Germany (2023-2034)
  • Table 13: Robotic Endoscopy Devices Market in United Kingdom (2023-2034)
  • Table 14: Robotic Endoscopy Devices Market in France (2023-2034)
  • Table 15: Robotic Endoscopy Devices Market in Italy (2023-2034)
  • Table 16: Robotic Endoscopy Devices Market in Spain (2023-2034)
  • Table 17: Robotic Endoscopy Devices Market in the Rest of Europe (2023-2034)
  • Table 18: Robotic Endoscopy Devices Market in Asia-Pacific (2023-2034)
  • Table 19: Robotic Endoscopy Devices Market in China (2023-2034)
  • Table 20: Robotic Endoscopy Devices Market in Japan (2023-2034)
  • Table 21: Robotic Endoscopy Devices Market in India (2023-2034)
  • Table 22: Robotic Endoscopy Devices Market in Australia (2023-2034)
  • Table 23: Robotic Endoscopy Devices Market in South Korea (2023-2034)
  • Table 24: Robotic Endoscopy Devices Market in Rest of Asia-Pacific (2023-2034)
  • Table 25: Robotic Endoscopy Devices Market in the Rest of the World (2023-2034)
  • Table 26: Robotic Endoscopy Devices Market in the Middle East (2023-2034)
  • Table 27: Robotic Endoscopy Devices Market in Africa (2023-2034)
  • Table 28: Robotic Endoscopy Devices Market in South America (2023-2034)
  • Table 29: Competitive Landscape
  • Table 30: Startup Funding and Investment Trends

List of Figures

  • Figure 1: Robotic Endoscopy Devices Market Drivers
  • Figure 2: Robotic Endoscopy Devices Market Restraints
  • Figure 3: Robotic Endoscopy Devices Market Opportunities
  • Figure 4: Impact Analysis: AI, Geopolitical, Trade, and Economic Developments
  • Figure 5: Regulatory Analysis (US, EU, Japan, China)
  • Figure 6: Porter's Five Forces Analysis
  • Figure 7: Competitive Analysis
  • Figure 8: Robotic Endoscopy Devices Market in Global (2023-2034)
  • Figure 9: Robotic Endoscopy Devices Market in Global by Product Type (2023-2034)
  • Figure 10: Robotic Endoscopy Devices Market in Global by Application (2023-2034)
  • Figure 11: Robotic Endoscopy Devices Market in Global by Technology (2023-2034)
  • Figure 12: Robotic Endoscopy Devices Market in Global by End User (2023-2034)
  • Figure 13: Robotic Endoscopy Devices Market in Global by Geography (2023-2034)
  • Figure 14: Robotic Endoscopy Devices Market in North America (2023-2034)
  • Figure 15: Robotic Endoscopy Devices Market in the United States (2023-2034)
  • Figure 16: Robotic Endoscopy Devices Market in Canada (2023-2034)
  • Figure 17: Robotic Endoscopy Devices Market in Mexico (2023-2034)
  • Figure 18: Robotic Endoscopy Devices Market in Europe (2023-2034)
  • Figure 19: Robotic Endoscopy Devices Market in Germany (2023-2034)
  • Figure 20: Robotic Endoscopy Devices Market in United Kingdom (2023-2034)
  • Figure 21: Robotic Endoscopy Devices Market in France (2023-2034)
  • Figure 22: Robotic Endoscopy Devices Market in Italy (2023-2034)
  • Figure 23: Robotic Endoscopy Devices Market in Spain (2023-2034)
  • Figure 24: Robotic Endoscopy Devices Market in the Rest of Europe (2023-2034)
  • Figure 25: Robotic Endoscopy Devices Market in Asia-Pacific (2023-2034)
  • Figure 26: Robotic Endoscopy Devices Market in China (2023-2034)
  • Figure 27: Robotic Endoscopy Devices Market in Japan (2023-2034)
  • Figure 28: Robotic Endoscopy Devices Market in India (2023-2034)
  • Figure 29: Robotic Endoscopy Devices Market in Australia (2023-2034)
  • Figure 30: Robotic Endoscopy Devices Market in South Korea (2023-2034)
  • Figure 31: Robotic Endoscopy Devices Market in Rest of Asia-Pacific (2023-2034)
  • Figure 32: Robotic Endoscopy Devices Market in the Rest of the World (2023-2034)
  • Figure 33: Robotic Endoscopy Devices Market in the Middle East (2023-2034)
  • Figure 34: Robotic Endoscopy Devices Market in Africa (2023-2034)
  • Figure 35: Robotic Endoscopy Devices Market in South America (2023-2034)
  • Figure 36: Competitive Landscape
  • Figure 37: Startup Funding and Investment Trends